Preventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation Benefit and Risks of Old and New Oral Anticoagulants

被引：34
|
作者：
Reinecke, Holger [1 ]
Engelbertz, Christiane [1 ]
Schaebitz, Wolf-Ruediger [2 ]
机构：
[1] Univ Hosp Muenster, Dept Cardiovasc Med, Div Vasc Med, Munster, Germany
[2] EvKB Bethel, Dept Neurol, Bielefeld, Germany
来源：
STROKE | 2013年 / 44卷 / 10期
关键词：
anticoagulation; atrial fibrillation; chronic kidney diseases; mortality; stroke; STAGE RENAL-DISEASE; SYSTEMIC EMBOLISM; WARFARIN; PREVALENCE; POPULATION; EFFICACY; DYSFUNCTION; VALIDATION; DABIGATRAN; MANAGEMENT;
D O I：
10.1161/STROKEAHA.113.001701
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2935 / 2941
页数：7
相关论文
共 50 条
  • [1] Oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
    Prkacin, Ingrid
    Cavric, Gordana
    Adam, Visnja Nesek
    Balenovic, Diana
    Horvat, Ivan
    Dobrota, Vesna Dermanovic
    Radocaj, Tomislav
    [J]. SIGNA VITAE, 2016, 11 : 41 - 43
  • [2] Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Ozbek, Kerem
    Cicekcioglu, Huelya
    Cetin, Mustafa
    Duyuler, Pinar Turker
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 266 - 266
  • [3] Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
    Stamellou, Eleni
    Floege, Juergen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (10) : 1683 - 1689
  • [4] Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
    Kimachi, Miho
    Furukawa, Toshi A.
    Kimachi, Kimihiko
    Goto, Yoshihito
    Fukuma, Shingo
    Fukuhara, Shunichi
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [5] Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants
    Jhawar, Manish B.
    Flaker, Greg
    [J]. JOURNAL OF BLOOD MEDICINE, 2012, 3 : 1 - 13
  • [6] Response to "Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease"
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Hoffman, Katherine
    Kim, Robert J.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 267 - 267
  • [7] Anticoagulants in atrial fibrillation patients with chronic kidney disease
    Hart, Robert G.
    Eikelboom, John W.
    Ingram, Alistair J.
    Herzog, Charles A.
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (10) : 569 - 578
  • [8] Anticoagulants in atrial fibrillation patients with chronic kidney disease
    Robert G. Hart
    John W. Eikelboom
    Alistair J. Ingram
    Charles A. Herzog
    [J]. Nature Reviews Nephrology, 2012, 8 : 569 - 578
  • [9] Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
    Sacquegna, Tommaso
    Zaniboni, Anna
    Rubboli, Andrea
    Procaccianti, Gaetano
    Crisci, Michela
    Maioli, Fabiola
    Arnone, Giorgia
    Di Pasquale, Giuseppe
    [J]. ITALIAN JOURNAL OF MEDICINE, 2015, 9 (04) : 314 - 322
  • [10] Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope
    Hohnloser, Stefan H.
    Connolly, Stuart J.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2347 - 2349
12345